EV/EBITDA
-0.04
+0.02+33.33%
Wed, 01 Jan 2025 00:59:26 GMT
Summary:
TransCode Therapeutics EV/EBITDA is currently -0.04, with a rise of +0.02 (+33.33%) during the most recent trading day. Over the past year, it has increased by +0.06 (+60.00%). RNAZ EV/EBITDA is now -113.33% below its all-time high of 0.30.RNAZ EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAZ EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +33.3% |
| 1 m1 month | +86.7% |
| 3 m3 months | +93.0% |
| 6 m6 months | +83.3% |
| ytdytd | +60.0% |
| 1 y1 year | +60.0% |
| 5 y5 years | - |
RNAZ EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -0.04 | at high | -0.35 | +88.6% |
| 3 m | 3 months | -0.04 | at high | -0.77 | +94.8% |
| 6 m | 6 months | 0.05 | -180.0% | -0.77 | +94.8% |
| 1 y | 1 year | 0.24 | -116.7% | -0.77 | +94.8% |
| 3 y | 3 years | 0.30 | -113.3% | -4.04 | +99.0% |
| 5 y | 5 years | 0.30 | -113.3% | -25.23 | +99.8% |
| alltime | all time | 0.30 | -113.3% | -25.23 | +99.8% |
TransCode Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -0.04(-60.0%) |
| 2023 | -0.10(-54.5%) |
| Date | Value |
|---|---|
| 2022 | -0.22(-88.4%) |
| 2021 | -1.89 |
FAQ
- What is TransCode Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for TransCode Therapeutics?
- What is RNAZ EV/EBITDA year-to-date change?
- What is TransCode Therapeutics EV/EBITDA year-on-year change?
What is TransCode Therapeutics EV/EBITDA?
The current EV/EBITDA of RNAZ is -0.04
What is the all time high EV/EBITDA for TransCode Therapeutics?
TransCode Therapeutics all-time high EV/EBITDA is 0.30
What is RNAZ EV/EBITDA year-to-date change?
TransCode Therapeutics EV/EBITDA has changed by +0.06 (+60.00%) since the beginning of the year
What is TransCode Therapeutics EV/EBITDA year-on-year change?
Over the past year, RNAZ EV/EBITDA has changed by +0.06 (+60.00%)